15+ Years Experience 6,000+ IVF Successes 70%+ Success Rate Book Your Consultation Today 15+ Years Experience 6,000+ IVF Successes 70%+ Success Rate Book Your Consultation Today
9099946050Book Consultation

When Is IVF the Right Next Step, and When Is It Too Early?

Dr. Pranay Shah, Director and Chief Fertility Consultant at Wellspring IVF & Women's Hospital Ahmedabad

Dr. Pranay Shah

MS (ObGy) · Director, Wellspring IVF
Fertility specialist discussing IVF timelines and treatment options with a couple in a clinic

Published: 2 September 2026

Medically reviewed by Dr. Pranay Shah, MS (ObGy), Director & Chief Fertility Consultant

Last medically reviewed: 2 September 2026

Wellspring IVF & Women’s Hospital, Ahmedabad · ART Reg. GS/AHD/024

IVF is recommended when a specific diagnosis makes natural or simpler treatment unlikely to work — blocked or absent fallopian tubes, severe male-factor infertility, advanced maternal age with reduced ovarian reserve — or when appropriate first-line treatment has already failed. It is too early when a treatable cause has not yet been looked for.

Very few couples arrive at a fertility clinic asking whether IVF will work. Almost everyone arrives asking a harder question: is it time yet? Waiting has a cost, because female fertility declines with age and that decline is not reversible. Acting too soon also has a cost. This article sets out how that decision is made — what current guidelines say, what Indian law defines, and which findings move IVF from “last resort” to “first-line”.

How Long Should a Couple Try Before Considering IVF?

The starting point is when to be evaluated, which is not the same as when to have IVF. Current guidance is consistent: twelve months of regular, unprotected intercourse before evaluation if the female partner is under 35; six months if she is 35 or older; and immediate evaluation, without waiting, if there is a known or suspected cause.

The American Society for Reproductive Medicine’s committee opinion on the fertility evaluation of women recommends starting evaluation after twelve months under 35 and after six months at 35 and above, with more immediate assessment above 40 or where a cause is already suspected — irregular cycles, known tubal or uterine disease, or endometriosis. The World Health Organization uses the same twelve-month interval in its definition of infertility, describing it as a disease of the male or female reproductive system defined by failure to achieve a pregnancy after twelve months or more of regular unprotected intercourse.

The United Kingdom’s National Institute for Health and Care Excellence published a fully updated fertility guideline, NG257, on 31 March 2026, replacing the long-standing CG156. It similarly advises specialist referral after twelve months, or at presentation for those aged 36 and over or with a known cause.

Table 1 — When evaluation should begin, by age and clinical context.

SituationHow long to try firstWhat should happen next
Female partner under 35, no known problem12 monthsFull couple evaluation: ovulation assessment, ovarian reserve, tubal patency, semen analysis
Female partner 35–396 monthsSame evaluation, but scheduled promptly — do not repeat a “wait and see” year
Female partner 40 or olderDo not waitImmediate evaluation and early treatment planning
Irregular or absent periodsDo not waitOvulatory assessment first; ovulation induction may resolve the problem without IVF
Known endometriosis, prior pelvic infection, pelvic surgery or ectopic pregnancyDo not waitTubal and pelvic assessment early, because tubal damage changes the treatment path
Two or more pregnancy lossesDo not waitRecurrent miscarriage evaluation — a different pathway from infertility evaluation
Any abnormal semen analysisDo not waitRepeat the test after an appropriate interval and assess the male partner properly

 

A point patients often miss: these intervals describe when to be investigated, not when to start IVF. Many couples referred at twelve months never need IVF. The evaluation is what tells you.

What Does Indian Law Say About Eligibility for IVF?

India regulates assisted reproduction through the Assisted Reproductive Technology (Regulation) Act, 2021 (Act No. 42 of 2021). Two provisions are directly relevant to timing.

First, the Act’s own definition of infertility is the inability to conceive after one year of unprotected coitus, or another proven medical condition preventing conception — the same twelve-month framing used internationally. Second, Section 21(g) of the ART (Regulation) Act, 2021 restricts ART services to a woman above twenty-one and below fifty years of age, and to a man above twenty-one and below fifty-five years of age. A registered ART clinic in India cannot lawfully provide treatment outside those limits.

These are statutory eligibility boundaries, not clinical recommendations. Being legally eligible at 48 does not mean IVF with one’s own eggs is clinically reasonable at 48. Conversely, the law places no lower bar on how long a couple must try if a definite cause is already documented. The clinical decision and the legal boundary are separate questions, and both have to be satisfied.

What Conditions Make IVF the First-Line Treatment Rather Than a Last Resort?

In some diagnoses IVF is not an escalation — it is the only treatment that addresses the mechanism of the problem. In those situations, trying simpler treatments first wastes time rather than saving it.

What in vitro fertilisation does that no other treatment does is bypass the fallopian tube entirely and place fertilisation under laboratory control. That single fact explains most of the indications below. Where the tube is the problem, or where sperm cannot reach or penetrate the egg unaided, moving the fertilisation step into the laboratory is the mechanism of treatment, not a shortcut to it.

Table 2 — Common diagnoses and the treatment they usually point to first.

DiagnosisUsual first-line approachWhy
Both fallopian tubes blocked, damaged or surgically absentIVF, as first-lineSperm and egg cannot meet in the tube. No amount of timing, medication or insemination changes this.
Severe male-factor infertility (very low count, very poor motility, surgically retrieved sperm)IVF with ICSIFertilisation requires a single sperm to be injected into the egg; insemination cannot compensate for the sperm deficit.
Age 38–40+ with reduced ovarian reserveIVF, often without a long trial of simpler treatmentTime is the limiting factor. Each additional untreated year reduces the number and genetic quality of available eggs.
Moderate to severe endometriosis with distorted pelvic anatomyIVF, frequently after surgical assessmentAdhesions and endometriomas impair ovum pick-up by the tube.
Ovulatory disorder such as PCOS, otherwise normal evaluationOvulation induction first, then inseminationThe defect is ovulation, which is often correctable. IVF is escalation only after these fail.
Mild male factor with normal female evaluationLifestyle and andrology review, then inseminationMany mild abnormalities improve or prove non-limiting. IVF is not the first answer.
Unexplained infertility of short durationContinued attempts or stimulated inseminationA meaningful proportion conceive without IVF. Escalation follows a defined period, not anxiety.
Known single-gene disorder requiring embryo testingIVF, as the enabling stepEmbryo genetic testing is only possible within an IVF cycle.
Planned gonadotoxic treatment such as chemotherapyUrgent fertility preservationThe window closes when treatment starts; this is time-critical, not elective.

 

When Is It Too Early for IVF?

IVF is premature whenever a treatable cause has not been excluded, or a reasonable first-line treatment has not been given a fair trial. In practice, four situations account for most of the couples who are offered IVF sooner than they need it.

  • The evaluation is incomplete. No tubal patency test, no ovarian reserve assessment, or a semen analysis never repeated. A single abnormal semen sample is not a diagnosis; sperm parameters vary considerably between samples.
  • Ovulation has not been treated. In an ovulatory disorder such as PCOS with otherwise normal tubes and semen, ovulation induction addresses the actual defect. Moving straight to IVF treats a problem the couple does not have.
  • A correctable structural problem has been left in place. A significant submucous fibroid, an endometrial polyp or an untreated hydrosalpinx can each reduce the chance of an embryo implanting. Correcting these before a cycle is usually the better sequence.
  • Short-duration unexplained infertility. Where every test is normal and the couple has been trying for a relatively short period, a proportion will conceive without treatment or with simpler treatment.

On that last point, NICE’s 2026 guideline takes a more graduated position than its predecessor. For unexplained subfertility after two years, it advises considering up to four cycles of intrauterine insemination with gonadotrophin stimulation before progressing to IVF, or proceeding directly to IVF where individual circumstances justify it. Insemination is cheaper, less invasive and, for a defined subgroup, effective enough to be worth attempting — but it is not the right answer when tubes are blocked or the sperm count is severely reduced.

What Does the Clinical Evidence Actually Show About Waiting?

Three findings should shape the decision more than anything else.

Infertility is common, and it is not a couple’s fault

The World Health Organization estimates that approximately one in every six people of reproductive age worldwide experience infertility in their lifetime, and notes that assisted reproductive technology remains unavailable, inaccessible or unaffordable in much of the world. That context matters in India, where treatment is largely self-funded and the cost of an unnecessary cycle is real.

Age acts on both egg number and egg quality

Guidelines advise earlier evaluation from the mid-thirties for a mechanistic reason. The pool of antral follicles falls progressively with age, and the proportion of oocytes carrying chromosomal errors rises. Ovarian reserve tests such as AMH and antral follicle count describe the quantity side of that equation reasonably well; they do not measure egg quality, and they are not reliable predictors of whether a pregnancy will occur. Age remains the stronger predictor of outcome. This is why a normal AMH at 41 is reassuring about response to stimulation but not about live birth.

Escalation should follow a diagnosis, not a calendar

Both ESHRE’s clinical guideline library and NICE’s NG257 frame treatment selection around the identified cause, the duration of infertility and the woman’s age together. A couple with bilateral tubal occlusion at eight months and a couple with unexplained infertility at eighteen months are not on the same pathway, even though the second has been trying for longer.

How This Decision Is Assessed at Wellspring IVF

At Wellspring IVF & Women’s Hospital, an ART-registered clinic (Reg. GS/AHD/024) in Satellite, Ahmedabad, led by Dr. Pranay Shah, MS (ObGy), the first consultation is an assessment, not a treatment recommendation. The sequence is deliberately conventional, because the conventional sequence is what identifies the couples who do not need IVF.

  1. A full history from both partners: cycle pattern, duration of infertility, previous pregnancies and losses, prior surgery, infections, medical conditions and medication.
  2. Assessment of ovulation, usually from the menstrual history first, with hormonal or ultrasound confirmation where the history is unclear.
  3. Ovarian reserve assessment using AMH together with antral follicle count on transvaginal ultrasound.
  4. Assessment of the uterine cavity and pelvis by ultrasound, with hysteroscopy where a cavity abnormality is suspected.
  5. Tubal patency assessment, typically by hysterosalpingography, or laparoscopy where pelvic pathology is likely.
  6. Semen analysis for the male partner, repeated and interpreted against current reference values before any conclusion is drawn.

This is the structured pathway described under how female infertility is assessed, and it converts a vague question — “should we do IVF?” — into a specific one: which step in conception is failing, and what is the least invasive treatment that addresses it? With more than 15 years of practice and over 6,000 successful IVF outcomes, Dr. Shah’s position is that a fertility unit is measured as much by the couples it advises against IVF as by the cycles it performs.

What This Means for Your Treatment Plan

If you take one operating rule from this article, take this one: get evaluated early, then treat according to the diagnosis. Early evaluation is almost never wasted. Early IVF sometimes is.

  • If your evaluation is normal and you are under 35 with a short duration of infertility, a period of expectant management or simpler treatment is reasonable.
  • If ovulation is the problem, ovulation induction — with or without IUI treatment — addresses the actual defect and should usually be attempted first.
  • If both tubes are blocked, sperm parameters are severely reduced, or you are in your late thirties or forties with reduced reserve, IVF is the appropriate first-line treatment and delaying it is the greater risk.
  • If you have already completed an adequate number of appropriately monitored insemination cycles without success, repeating them is unlikely to change the outcome.

Couples who want to understand what the treatment itself involves before deciding will find the sequence set out in The IVF timeline, day by day, which walks through a cycle from stimulation to pregnancy test. Success rates at Wellspring exceed 70% in favourable groups, but that figure varies substantially with age, ovarian reserve, sperm parameters, embryo quality and the underlying indication, and it should never be read as an expected result for an individual couple.

When Should You Speak to a Fertility Specialist?

Arrange a consultation without waiting for a twelve-month interval to pass if any of the following apply.

  • The female partner is 35 or older and you have been trying for six months, or is 40 or older at any point.
  • Periods are irregular, very infrequent or absent.
  • There is known or suspected endometriosis, a previous ectopic pregnancy, previous pelvic infection or previous pelvic or tubal surgery.
  • There have been two or more miscarriages.
  • A semen analysis has shown a significantly reduced count, motility or morphology, or no sperm at all.
  • Either partner has had cancer treatment, or is about to begin it.
  • There is a known genetic condition in either family that could be transmitted.

Seek same-day medical attention, rather than a routine appointment, for severe pelvic pain, heavy abnormal bleeding, fever with pelvic pain, or pain with a positive pregnancy test and a pregnancy not yet confirmed inside the uterus.

Frequently Asked Questions

When is IVF recommended instead of continuing to try naturally?

IVF is recommended when a diagnosis makes natural conception unlikely — blocked or absent tubes, severe male-factor infertility, or advanced maternal age with reduced ovarian reserve — or when appropriate first-line treatment has failed. It is not recommended purely on the basis of how long a couple has been trying, without an evaluation that explains why.

How long should a couple try before considering IVF?

Evaluation should begin after twelve months of regular unprotected intercourse if the woman is under 35, and after six months if she is 35 or older. IVF itself follows the evaluation, not the interval. Where a definite cause such as tubal blockage is found, treatment does not wait for any further period of trying.

What conditions make IVF the first-line treatment rather than a last resort?

Bilateral tubal blockage or absent tubes, severe male-factor infertility requiring ICSI or surgical sperm retrieval, advanced maternal age with diminished ovarian reserve, significant endometriosis with distorted anatomy, and any situation requiring preimplantation genetic testing. In these, IVF addresses the mechanism directly rather than escalating from simpler treatment.

Can we do IVF without completing all the tests?

It is not advisable. Without tubal, uterine, ovarian reserve and semen assessment, a cycle may be planned around the wrong problem — for example proceeding with an untreated hydrosalpinx or an undiagnosed cavity abnormality, both of which can reduce the chance of implantation. Complete evaluation improves both the decision and the cycle.

Does a normal AMH mean we can safely wait?

No. AMH reflects the number of remaining follicles and helps predict how the ovaries will respond to stimulation. It does not measure egg quality and is not a reliable predictor of pregnancy or live birth. A woman of 40 with a reassuring AMH still faces the age-related rise in chromosomally abnormal eggs.

Is there an age limit for IVF in India?

Yes. Under Section 21(g) of the ART (Regulation) Act, 2021, a registered ART clinic in India may provide treatment to a woman above 21 and below 50 years of age, and to a man above 21 and below 55 years. This is a legal boundary; the clinical advice within it is individual.

Speak to a Fertility Specialist

If you are unsure whether it is time to move to IVF — or want a second opinion on a plan you have already been given — an evaluation-first consultation will tell you which step in conception is failing and what the least invasive effective treatment is. You can discuss your individual situation with the fertility team at Wellspring IVF & Women’s Hospital, Ahmedabad.

Consultation and WhatsApp: +91 9099946050

OPD hours: Monday to Saturday, 10:00 AM – 4:00 PM. Sunday closed.

Titanium City Center Mall, 440, 100 Feet Rd, near Sachin Tower, Anandnagar, Satellite, Ahmedabad, Gujarat 380015.

References

  1. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. NICE guideline NG257. Published 31 March 2026 (updates and replaces CG156). https://www.nice.org.uk/guidance/ng257
  2. Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion (2021). https://www.asrm.org/practice-guidance/practice-committee-documents/
  3. World Health Organization. Infertility — fact sheet. Updated 28 November 2025. https://www.who.int/news-room/fact-sheets/detail/infertility
  4. European Society of Human Reproduction and Embryology. Guidelines and legal — clinical guideline library. https://www.eshre.eu/Guidelines-and-Legal/Guidelines
  5. Government of India. The Assisted Reproductive Technology (Regulation) Act, 2021 (Act No. 42 of 2021), Sections 2 and 21(g). https://www.indiacode.nic.in/

This article is intended for general information and does not replace individual medical advice. Treatment decisions must be based on a personal clinical assessment. Medically reviewed by Dr. Pranay Shah, MS (ObGy), Director & Chief Fertility Consultant, Wellspring IVF & Women’s Hospital, Ahmedabad.

Dr. Pranay Shah, Director and Chief Fertility Consultant at Wellspring IVF & Women's Hospital Ahmedabad
Dr. Pranay Shah
MS (ObGy) · Director & Chief Fertility Consultant, Wellspring IVF
15+ years experience · 6,000+ IVF successes · Expert in personalised IVF protocols and complex infertility cases